Радиочастотная аблация «субстратных» желудочковых тахикардий: исторические аспекты и современное состояние

Несмотря на эффективную профилактику внезапной сердечной смерти при структурных заболеваниях сердца, вопрос снижения бремени желудочковых аритмий остается актуальным. Ограниченные возможности и потенциальные побочные эффекты антиаритмической терапии заставляют все чаще обращаться к интервенционному лечению желудочковых тахикардий (ЖТ), которое прошло долгий исторический путь от операций на открытом сердце к катетерным технологиям. Место катетерной аблации субстратных ЖТ на сегодняшний день окончательно не определено, как и оптимальные подходы к выполнению данных операций. Понимание подводных камней доказательной базы, возможностей и ограничений катетерной аблации будет полезно для эффективного оказания помощи пациентам с субстратными ЖТ.

1. Bayés de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J. 1989;117(1): 151-9. https://doi.org/10.1016/0002-8703(89)90670-4.

2. Tilz RR, Lin T, Eckardt L, et al. Ablation Outcomes and Predictors of Mortality Following Catheter Ablation for Ventricular Tachycardia: Data From the German Multicenter Ablation Registry. J Am Heart Assoc. 2018;7(6): e007045. https://doi.org/10.1161/JAHA.117.007045.

3. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40): 3997-4126. https://doi.org/10.1093/eurheartj/ehac262.

4. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359(10): 1009-17. https://doi.org/10.1056/NEJMoa071098.

5. Wasserman E, Yules J. Cardiac aneurysm with ventricular tachycardia: case report and brief review of the literature. Ann Intern Med. 1953;39(4): 948-56. https://doi.org/10.7326/0003-4819-39-4-948.

6. Couch OA. Cardiac aneurysm with ventricular tachycardia and subsequent excision of aneurysm; case report. Circulation. 1959;20(2): 251-3. https://doi.org/10.1161/01.cir.20.2.251.

7. Wellens HJ, Schuilenburg RM, Durrer D. Electrical stimulation of the heart in patients with ventricular tachycardia. Circulation. 1972;46(2): 216-26. https://doi.org/10.1161/01.cir.46.2.216.

8. Gallagher JJ, Oldham HN, Wallace AG, et al. Ventricular aneurysm with ventricular tachycardia. Report of a case with epicardial mapping and successful resection. Am J Cardiol. 1975;35(5): 696-700. https://doi.org/10.1016/0002-9149(75)90059-4.

9. Guiraudon G, Fontaine G, Frank R, et al. Encircling endocardial ventriculotomy: a new surgical treatment for life-threatening ventricular tachycardias resistant to medical treatment following myocardial infarction. Ann Thorac Surg. 1978;26(5): 438-44. https://doi.org/10.1016/s0003-4975(10)62923-2.

10. Josephson ME, Horowitz LN, Farshidi A, et al. Recurrent sustained ventricular tachycardia. 1. Mechanisms. Circulation. 1978;57(3): 431-40. https://doi.org/10.1161/01.cir.57.3.431.

11. Josephson ME, Horowitz LN, Farshidi A, et al. Recurrent sustained ventricular tachycardia. 2. Endocardial mapping. Circulation. 1978;57(3): 440-7. https://doi.org/10.1161/01.cir.57.3.440.

12. Josephson ME, Harken AH, Horowitz LN. Endocardial excision: a new surgical technique for the treatment of recurrent ventricular tachycardia. Circulation. 1979;60(7): 1430-9. https://doi.org/10.1161/01.cir.60.7.1430.

13. Shenasa M, Miller JM, Callans DJ, et al. Conquest of Ventricular Tachycardia: Insights Into Mechanisms, Innovations in Management. Circ Arrhythm Electrophysiol. 2017;10(5): e005150. https://doi.org/10.1161/CIRCEP.117.005150.

14. Miller JM, Kienzle MG, Harken AH, et al. Subendocardial resection for ventricular tachycardia: predictors of surgical success. Circulation. 1984;70(4): 624-31. https://doi.org/10.1161/01.cir.70.4.624.

15. Hargrove WC, Miller JM, Vassallo JA, et al. Improved results in the operative management of ventricular tachycardia related to inferior wall infarction. Importance of the annular isthmus. J Thorac Cardiovasc Surg. 1986;92(4): 726-32.

16. Josephson ME, Waxman HL, Cain ME, et al. Ventricular activation during ventricular endocardial pacing. II. Role of pace-mapping to localize origin of ventricular tachycardia. Am J Cardiol. 1982;50(1): 11-22. https://doi.org/10.1016/0002-9149(82)90003-0.

17. Josephson ME, Horowitz LN, Waxman HL, et al. Sustained ventricular tachycardia: role of the 12-lead electrocardiogram in localizing site of origin. Circulation. 1981;64(2): 257-72. https://doi.org/10.1161/01.cir.64.2.257.

18. Josephson ME, Harken AH, Horowitz LN. Longterm results of endocardial resection for sustained ventricular tachycardia in coronary disease patients. Am Heart J. 1982;104(1): 51-7. https://doi.org/10.1016/0002-8703(82)90640-8.

19. Miller JM, Marchlinski FE, Harken AH, et al. Subendocardial resection for sustained ventricular tachycardia in the early period after acute myocardial infarction. Am J Cardiol. 1985;55(8): 980-4. https://doi.org/10.1016/0002-9149(85)90730-1.

20. Hartzler GO. Electrode catheter ablation of refractory focal ventricular tachycardia. J Am Coll Cardiol. 1983;2(6): 1107-13. https://doi.org/10.1016/s0735-1097(83)80337-4.

21. Josephson ME, Horowitz LN, Spielman SR, et al. Role of catheter mapping in the preoperative evaluation of ventricular tachycardia. Am J Cardiol. 1982;49(1): 207-20. https://doi.org/10.1016/0002-9149(82)90295-8.

22. Лебедев ДС. Совершенствование и оценка эффективности диагностики и хирургического лечения жизнеопасных нарушений ритма сердца. В кн. Диссертация на соискание ученой степени доктора медицинских наук. 2004: 195-197.

23. Gardner PI, Ursell PC, Fenoglio JJ, et al. Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation. 1985;72(3): 596-611. https://doi.org/10.1161/01.cir.72.3.596.

24. Stevenson WG, Weiss JN, Wiener I, et al. Fractionated endocardial electrograms are associated with slow conduction in humans: evidence from pace-mapping. J Am Coll Cardiol. 1989;13(2): 369-76. https://doi.org/10.1016/0735-1097(89)90514-7.

25. Fitzgerald DM, Friday KJ, Wah JA, et al. Electrogram patterns predicting successful catheter ablation of ventricular tachycardia. Circulation. 1988;77(4): 806-14. https://doi.org/10.1161/01.cir.77.4.806.

26. Stevenson WG, Khan H, Sager P, et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation. 1993;88(4 Pt 1): 1647-70. https://doi.org/10.1161/01.cir.88.4.1647.

27. Stevenson WG, Friedman PL, Sager PT, et al. Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. J Am Coll Cardiol. 1997;29(6): 1180-9. https://doi.org/10.1016/s0735-1097(97)00065-x.

28. Sosa E, Scanavacca M, d’Avila A, et al. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 1996;7(6): 531-6. https://doi.org/10.1111/j.1540-8167.1996.tb00559.x.

29. Marchlinski FE, Callans DJ, Gottlieb CD, et al. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000;101(11): 1288-96. https://doi.org/10.1161/01.cir.101.11.1288.

30. Гасымова НЗ, Шабанов ВВ, Сафонов НВ и др. Многоконтактное картирование в лечении различных нарушений ритма сердца. Вестник аритмологии. 2024;31(1): 110-122. https://doi.org/10.35336/VA-1297.

31. Stevenson WG, Friedman PL, Ganz LI. Radiofrequency catheter ablation of ventricular tachycardia late after myocardial infarction. J Cardiovasc Electrophysiol. 1997;8(11): 1309-19. https://doi.org/10.1111/j.1540-8167.1997.tb01023.x.

32. Tung R. Challenges and Pitfalls of Entrainment Mapping of Ventricular Tachycardia: Ten Illustrative Concepts. Circ Arrhythm Electrophysiol. 2017;10(4): e004560. https://doi.org/10.1161/CIRCEP.116.004560.

33. Brunckhorst CB, Delacretaz E, Soejima K, et al. Identification of the ventricular tachycardia isthmus after infarction by pace mapping. Circulation. 2004;110(6): 652-9. https://doi.org/10.1161/01.CIR.0000138107.11518.AF.

34. de Chillou C, Sellal JM, Magnin-Poull I. Pace Mapping to Localize the Critical Isthmus of Ventricular Tachycardia. Card Electrophysiol Clin. 2017;9(1): 71-80. https://doi.org/10.1016/j.ccep.2016.10.005.

35. Tung R, Kim S, Yagishita D, et al. Scar voltage threshold determination using ex vivo magnetic resonance imaging integration in a porcine infarct model: Influence of interelectrode distances and three-dimensional spatial effects of scar. Heart Rhythm. 2016;13(10): 1993-2002. https://doi.org/10.1016/j.hrthm.2016.07.003.

36. Josephson ME, Anter E. Substrate Mapping for Ventricular Tachycardia. JACC Clin Electrophysiol. 2015;1(5): 341-52. https://doi.org/10.1016/j.jacep.2015.09.001.

37. Mills MT, Calvert P, Chiong J, et al. Dynamic Voltage Mapping of the Post-infarct Ventricular Tachycardia Substrate: A Practical Technique to Help Differentiate Scar from Borderzone Tissue. Arrhythm Electrophysiol Rev. 2024;14;13: e16. https://doi.org/10.15420/aer.2024.26.

38. Piers SRD, van Huls van Taxis CFB, Tao Q, et al. Epicardial substrate mapping for ventricular tachycardia ablation in patients with non-ischaemic cardiomyopathy: a new algorithm to differentiate between scar and viable myocardium developed by simultaneous integration of computed tomography and contrast-enhanced magnetic resonance imaging. Eur Heart J. 2013;34(8): 586-96. https://doi.org/10.1093/eurheartj/ehs382.

39. Polin GM, Haqqani H, Tzou W, et al. Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm. 2011;8(1): 76-83. https://doi.org/10.1016/j.hrthm.2010.09.088.

40. Chaumont C, Peyster EG, Siontis KC, et al. Unipolar Voltage Mapping to Predict Recovery of Left Ventricular Ejection Fraction in Patients With Recent-Onset Nonischemic Cardiomyopathy. Circulation. 2025;151(6): 368-78. https://doi.org/10.1161/CIRCULATIONAHA.124.070501.

41. Anter E. Limitations and Pitfalls of Substrate Mapping for Ventricular Tachycardia. JACC Clin Electrophysiol. 2021;7(4): 542-60. https://doi.org/10.1016/j.jacep.2021.02.007.

42. de Bakker JM, van Capelle FJ, Janse MJ, et al. Slow conduction in the infarcted human heart. «Zigzag» course of activation. Circulation. 1993;88(3): 915-26. https://doi.org/10.1161/01.cir.88.3.915.

43. Tsiachris D, Silberbauer J, Maccabelli G, et al. Electroanatomical voltage and morphology characteristics in postinfarction patients undergoing ventricular tachycardia ablation: pragmatic approach favoring late potentials abolition. Circ Arrhythm Electrophysiol. 2015;8(4): 863-73. https://doi.org/10.1161/CIRCEP.114.002551.

44. Anter E, Tschabrunn CM, Buxton AE, et al. High-Resolution Mapping of Postinfarction Reentrant Ventricular Tachycardia. Circulation. 2016;134(2): 144-63. https://doi.org/10.1161/CIRCULATIONAHA.116.021955.

45. Jaïs P, Maury P, Khairy P, et al. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation. 2012;125(18): 2184-96. https://doi.org/10.1161/CIRCULATIONAHA.111.043216.

46. Srinivasan NT, Orini M, Providencia R, et al. Prolonged action potential duration and dynamic transmural action potential duration heterogeneity underlie vulnerability to ventricular tachycardia in patients undergoing ventricular tachycardia ablation. Europace. 2019;21(4): 616-25. https://doi.org/10.1093/europace/euy260.

47. Uotani Y, Okubo Y, Komatsu Y, et al. Isochronal late activation mapping of epicardial ventricular tachycardia in a patient with midventricular obstructive hypertrophic cardiomyopathy. HeartRhythm Case Rep. 2022;8(5): 374-7. https://doi.org/10.1016/j.hrcr.2022.03.001.

48. Irie T, Yu R, Bradfield JS, et al. Relationship between sinus rhythm late activation zones and critical sites for scar-related ventricular tachycardia: systematic analysis of isochronal late activation mapping. Circ Arrhythm Electrophysiol. 2015;8(2): 390-9. https://doi.org/10.1161/CIRCEP.114.002637.

49. Raiman M, Tung R. Automated isochronal late activation mapping to identify deceleration zones: Rationale and methodology of a practical electroanatomic mapping approach for ventricular tachycardia ablation. Comput Biol Med. 2018;102: 336-40. https://doi.org/10.1016/j.compbiomed.2018.07.012.

50. Aziz Z, Shatz D, Raiman M, et al. Targeted Ablation of Ventricular Tachycardia Guided by Wavefront Discontinuities During Sinus Rhythm: A New Functional Substrate Mapping Strategy. Circulation. 2019;140(17): 1383-97. https://doi.org/10.1161/CIRCULATIONAHA.119.042423.

51. Jackson N, Gizurarson S, Viswanathan K, et al. Decrement Evoked Potential Mapping: Basis of a Mechanistic Strategy for Ventricular Tachycardia Ablation. Circ Arrhythm Electrophysiol. 2015;8(6): 1433-42. https://doi.org/10.1161/CIRCEP.115.003083.

52. Porta-Sánchez A, Jackson N, Lukac P, et al. Multicenter Study of Ischemic Ventricular Tachycardia Ablation With Decrement-Evoked Potential (DEEP) Mapping With Extra Stimulus. JACC Clin Electrophysiol. 2018;4(3): 307-15. https://doi.org/10.1016/j.jacep.2017.12.005.

53. Niri A, Shapira E, Massé S, et al. Automated Identification of Ventricular Tachycardia Ablation Targets: Multicenter Validation and Workflow Characterization. J Innov Card Rhythm Manag. 2022;13(9): 5147-52. https://doi.org/10.19102/icrm.2022.130903.

54. Rossi P, Cauti FM, Niscola M, et al. A novel Ventricular map of Electrograms DUration as a Method to identify areas of slow conduction for ventricular tachycardia ablation: The VEDUM pilot study. Heart Rhythm. 2021;18(8): 1253-60. https://doi.org/10.1016/j.hrthm.2021.04.030.

55. Shariat MH, Gupta D, Gul EE, et al. Ventricular substrate identification using close-coupled paced electrogram feature analysis. Europace. 2019;21(3): 492-501. https://doi.org/10.1093/europace/euy265.

56. Haaf P, Garg P, Messroghli DR, et al. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson. 2016;18(1): 89. https://doi.org/10.1186/s12968-016-0308-4.

57. Desjardins B, Crawford T, Good E, et al. Infarct architecture and characteristics on delayed enhanced magnetic resonance imaging and electroanatomic mapping in patients with postinfarction ventricular arrhythmia. Heart Rhythm. 2009;6(5): 644-51. https://doi.org/10.1016/j.hrthm.2009.02.018.

58. Piers SRD, Tao Q, de Riva Silva M, et al. CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia. JACC Cardiovasc Imaging. 2014;7(8): 774-84. https://doi.org/10.1016/j.jcmg.2014.03.013.

59. Sasaki T, Miller CF, Hansford R, et al. Impact of nonischemic scar features on local ventricular electrograms and scar-related ventricular tachycardia circuits in patients with nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol. 2013;6(6): 1139-47. https://doi.org/10.1161/CIRCEP.113.000159.

60. Sasaki T, Hansford R, Zviman MM, et al. Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators. Circ Cardiovasc Imaging. 2011;4(6): 662-70. https://doi.org/10.1161/CIRCIMAGING.111.965764.

61. Sasaki T, Calkins H, Miller CF, et al. New insight into scar-related ventricular tachycardia circuits in ischemic cardiomyopathy: Fat deposition after myocardial infarction on computed tomography - A pilot study. Heart Rhythm. 2015;12(7): 1508-18. https://doi.org/10.1016/j.hrthm.2015.03.041.

62. Englert F, Bahlke F, Erhard N, et al. VT ablation based on CT imaging substrate visualization: results from a large cohort of ischemic and non-ischemic cardiomyopathy patients. Clin Res Cardiol. 2024;113(10): 1478-84. https://doi.org/10.1007/s00392-023-02321-1.

63. Vergara P, Trevisi N, Ricco A, et al. Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation. J Cardiovasc Electrophysiol. 2012;23(6): 621-7. https://doi.org/10.1111/j.1540-8167.2011.02246.x.

64. Berruezo A, Fernández-Armenta J, Andreu D, et al. Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation. Circ Arrhythm Electrophysiol. 2015;8(2): 326-36. https://doi.org/10.1161/CIRCEP.114.002386.

65. Tzou WS, Frankel DS, Hegeman T, et al. Core Isolation of Critical Arrhythmia Elements for Treatment of Multiple Scar-Based Ventricular Tachycardias. Circ Arrhythm Electrophysiol. 2015;8(2): 353-61. https://doi.org/10.1161/CIRCEP.114.002310.

66. Di Biase L, Santangeli P, Burkhardt DJ, et al. Endoepicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2012;60(2): 132-41. https://doi.org/10.1016/j.jacc.2012.03.044.

67. Di Biase L, Burkhardt JD, Lakkireddy D, et al. Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial. J Am Coll Cardiol. 2015;66(25): 2872-82. https://doi.org/10.1016/j.jacc.2015.10.026.

68. Dinov B, Arya A, Schratter A, et al. Catheter Ablation of Ventricular Tachycardia and Mortality in Patients With Nonischemic Dilated Cardiomyopathy. Circ Arrhythm Electrophysiol. 2015;8(3): 598-605. https://doi.org/10.1161/CIRCEP.114.002295.

69. Radinovic A, Peretto G, Sgarito G, et al. Matching Ablation Endpoints to Long-Term Outcome. JACC Clin Electrophysiol. 2023;9(6): 836-47. https://doi.org/10.1016/j.jacep.2022.10.038.

70. Аманатова ВА, Хачиров МР, Ускач ТМ, и др. Оценка индекса аблации при проведении катетерного лечения у пациентов с ишемической болезнью сердца и систолической дисфункцией. Вестник аритмологии. 2025;32(3): 29-36. https://doi.org/10.35336/VA-1479.

71. Barkagan M, Rottmann M, Leshem E, et al. Effect of Baseline Impedance on Ablation Lesion Dimensions: A Multimodality Concept Validation From Physics to Clinical Experience. Circ Arrhythm Electrophysiol. 2018;11(10): e006690. https://doi.org/10.1161/CIRCEP.118.006690.

72. Shapira-Daniels A, Barkagan M, Rottmann M, et al. Modulating the Baseline Impedance: An Adjunctive Technique for Maximizing Radiofrequency Lesion Dimensions in Deep and Intramural Ventricular Substrate. Circ Arrhythm Electrophysiol. 2019;12(6): e007336. https://doi.org/10.1161/CIRCEP.119.007336.

73. Futyma P, Kułakowski P. Frontal placement of dispersive patch for effective ablation of arrhythmia originating from the anterior right ventricular outflow tract. J Interv Card Electrophysiol. 2017;49(3): 327. https://doi.org/10.1007/s10840-017-0263-5.

74. Nguyen DT, Gerstenfeld EP, Tzou WS, et al. Radiofrequency Ablation Using an Open Irrigated Electrode Cooled With Half-Normal Saline. JACC Clin Electrophysiol. 2017;3(10): 1103-10. https://doi.org/10.1016/j.jacep.2017.03.006.

75. Tschabrunn CM, Pothineni NVK, Sauer WH, et al. Evaluation of Radiofrequency Ablation Irrigation Type: In Vivo Comparison of Normal Versus Half-Normal Saline Lesion Characteristics. JACC Clin Electrophysiol. 2020;6(6): 684-92. https://doi.org/10.1016/j.jacep.2020.02.013.

76. Nguyen DT, Tzou WS, Sandhu A, et al. Prospective Multicenter Experience With Cooled Radiofrequency Ablation Using High Impedance Irrigant to Target Deep Myocardial Substrate Refractory to Standard Ablation. JACC Clin Electrophysiol. 2018;4(9): 1176-85. https://doi.org/10.1016/j.jacep.2018.06.021.

77. Dong Y, Wang H, Ma K, et al. Half versus normal saline irrigation during catheter ablation of outflow tract ventricular arrhythmias (HALF): a multi-center, parallel, open-label, randomized controlled study. J Interv Card Electrophysiol. 2023;66(9): 2143-51. https://doi.org/10.1007/s10840-023-01558-0.

78. Chang RJ, Stevenson WG, Saxon LA, et al. Increasing catheter ablation lesion size by simultaneous application of radiofrequency current to two adjacent sites. Am Heart J. 1993;125(5 Pt 1): 1276-84. https://doi.org/10.1016/0002-8703(93)90995-l.

79. Yang J, Liang J, Shirai Y, et al. Outcomes of simultaneous unipolar radiofrequency catheter ablation for intramural septal ventricular tachycardia in nonischemic cardiomyopathy. Heart Rhythm. 2019;16(6): 863-70. https://doi.org/10.1016/j.hrthm.2018.12.018.

80. Futyma P, Sultan A, Zarębski Ł, et al. Bipolar radiofrequency ablation of refractory ventricular arrhythmias: results from a multicentre network. Europace. 2024;26(10): euae248. https://doi.org/10.1093/europace/euae248.

81. Fernandes GC, Nguyen T, Creed E, et al. Multipolar Ablation Using Mapping Electrodes: A Novel Approach to Intramural Arrhythmia Substrates. JACC Clin Electrophysiol. 2023;9(5): 680-5. https://doi.org/10.1016/j.jacep.2022.10.029.

82. Younis A, Yavin HD, Higuchi K, et al. Increasing Lesion Dimensions of Bipolar Ablation by Modulating the Surface Area of the Return Electrode. JACC Clin Electrophysiol. 2022;8(4): 498-510. https://doi.org/10.1016/j.jacep.2022.01.002.

83. Della Bella P, Peretto G, Paglino G, et al. Bipolar radiofrequency ablation for ventricular tachycardias originating from the interventricular septum: Safety and efficacy in a pilot cohort study. Heart Rhythm. 2020;17(12): 2111-8. https://doi.org/10.1016/j.hrthm.2020.06.025.

84. Futyma P, Chen S, Enriquez A, et al. Bipolar ablation of ventricular arrhythmias: Step‐by‐step. J Cardiovasc Electrophysiol. 2023;34(12): 2599-606. https://doi.org/10.1111/jce.16131.

85. Woo EJ, Tungjitkusolmun S, Cao H, et al. A new catheter design using needle electrode for subendocardial RF ablation of ventricular muscles: finite element analysis and in vitro experiments. IEEE Trans Biomed Eng. 2000;47(1): 23-31. https://doi.org/10.1109/10.817616.

86. Sapp JL, Beeckler C, Pike R, et al. Initial human feasibility of infusion needle catheter ablation for refractory ventricular tachycardia. Circulation. 2013;128(21): 2289-95. https://doi.org/10.1161/CIRCULATIONAHA.113.003423.

87. Stevenson WG, Tedrow UB, Reddy V, et al. Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricular Arrhythmias. J Am Coll Cardiol. 2019;73(12): 1413-25. https://doi.org/10.1016/j.jacc.2018.12.070.

88. Kurata M, Batnyam U, Tedrow UB, et al. Intramural needle ablation or repeated standard ablation in patients referred for repeat ablation of scar‐related ventricular tachycardia. J Cardiovasc Electrophysiol. 2024;35(5): 994-1004. https://doi.org/10.1111/jce.16250.

89. Packer DL, Wilber DJ, Kapa S, et al. Ablation of Refractory Ventricular Tachycardia Using Intramyocardial Needle Delivered Heated Saline-Enhanced Radiofrequency Energy: A First-in-Man Feasibility Trial. Circ Arrhythm Electrophysiol. 2022;15(8): e010347. https://doi.org/10.1161/CIRCEP.121.010347.

90. Santos RR, Paiva MS, Amador R, et al. Ventricular tachycardia: Focal pulsed field electroporation as a rescue therapy. Heart Rhythm O2. 2024;5(11): 839-41. https://doi.org/10.1016/j.hroo.2024.09.016.

91. Zhang Z, Xiao Y, Wang C, et al. Pulsed field ablation: A promising approach for ventricular tachycardia ablation. Int J Cardiol. 2024;407: 131985. https://doi.org/10.1016/j.ijcard.2024.131985.

92. Sanborn L, Schricker AA, Tooley J, et al. Failure of Transmural Posterior Wall Isolation by Pulse Field Ablation Demonstrated With Epicardial Mapping. JACC Clin Electrophysiol. 2025; Preprint. https://doi.org/10.1016/j.jacep.2025.08.017.

93. Tokuda M, Sobieszczyk P, Eisenhauer AC, et al. Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update. Circ Arrhythm Electrophysiol. 2011;4(6): 889-96. https://doi.org/10.1161/CIRCEP.111.966283.

94. Ревишвили АШ, Васковский ВА, Артюхина ЕА, и др. Применение стереотаксической радиоаблации в клинической практике для лечения пациента с желудочковой тахикардией: клиническое наблюдение. Вестник аритмологии. 2022;29(4): 66-72. https://doi.org/10.35336/VA-2022-4-10.

95. Коробченко ЛЕ, Кондори Леандро ЭИ, Вахрушев АД, и др. Транскатетерная окклюзия коронарного синуса увеличивает объем повреждения при радиочастотной аблации миокарда левого желудочка: новый подход к повышению эффективности деструкции субстрата желудочковых тахиаритмий. Вестник аритмологии. 2023;30(4): 69-75. https://doi.org/10.35336/VA-1207.

96. Коробченко ЛЕ, Вахрушев АД, Кондори ЛЭИ, и др. Радиочастотная модификация «глубокого» интрамиокардиального электрофизиологического субстрата на фоне окклюзии коронарного синуса: успешное лечение левожелудочковой тахикардии, рефрактерной к стандартной эндо-эпикардиальной аблации. Российский Кардиологический Журнал. 2024 г.;29(S5): 35-6.

97. Samuel M, Elsokkari I, Sapp JL. Ventricular Tachycardia Burden and Mortality: Association or Causality? Can J Cardiol. 2022;38(4): 454-64. https://doi.org/10.1016/j.cjca.2022.01.016.

98. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357(26): 2657-65. https://doi.org/10.1056/NEJMoa065457.

99. Kuck KH, Schaumann A, Eckardt L, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375(9708): 31-40. https://doi.org/10.1016/S0140-6736(09)61755-4.

100. Kuck KH, Tilz RR, Deneke T, et al. Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study). Circ Arrhythm Electrophysiol. 2017;10(3): e004422. https://doi.org/10.1161/CIRCEP.116.004422.

101. Žižek D, Mrak M, Jan M, et al. Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion. Europace. 2024;26(5): euae109. https://doi.org/10.1093/europace/euae109.

102. Willems S, Tilz RR, Steven D, et al. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial. Circulation. 2020;141(13): 1057-67. https://doi.org/10.1161/CIRCULATIONAHA.119.043400.

103. Tung R, Xue Y, Chen M, et al. First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial. Circulation. 2022;145(25): 1839-49. https://doi.org/10.1161/CIRCULATIONAHA.122.060039.

104. Sapp JL, Wells GA, Parkash R, et al. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. N Engl J Med. 2016;375(2): 111-21. https://doi.org/10.1056/NEJMoa1513614.

105. Della Bella P, Baratto F, Vergara P, et al. Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial. Circulation. 2022;145(25): 1829-38. https://doi.org/10.1161/CIRCULATIONAHA.122.059598.

106. Sapp JL, Tang ASL, Parkash R, et al. Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia. N Engl J Med. 2025;392(8): 737-47. https://doi.org/10.1056/NEJMoa2409501.